CDX-1140
CDX-1140 is a human IgG2 CD40 agonist antibody. CDX-1140 activates dendritic cells (DCs) and B cells and drives NF-kB stimulation in a CD40-expressing reporter cell line. CDX-1140 is independent of FcR binding and synergistic with native CD40L signaling. CDX-1140 has both direct and immune-mediated anti-tumor activity. CDX-1140 can be used for the study of lymphoma cancer and solid tumors[1][2].
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Vitale LA, et al. Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy. Cancer Immunol Immunother. 2019 Feb;68 (2) :233-245.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15195088 1 Vial
Lentiviral mouse Rps6ka5 shRNA (UAS) - Lentiviral mouse Rps6ka5 shRNA (UAS, iRFP) plasmid
Ask
View Details MBS6354209-01 0.2 mL
TBX3, ID (TBX3, T-box transcription factor TBX3) (Azide free) (HRP)
Ask
View Details 
MBS6354209-02 5x 0.2 mL
TBX3, ID (TBX3, T-box transcription factor TBX3) (Azide free) (HRP)
Ask
View Details 